SK56390A3 - Ether 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxyacids, preparation method of it, intermediate product of this method, pharmaceutical composition containing said ether and use - Google Patents

Ether 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxyacids, preparation method of it, intermediate product of this method, pharmaceutical composition containing said ether and use Download PDF

Info

Publication number
SK56390A3
SK56390A3 SK563-90A SK56390A SK56390A3 SK 56390 A3 SK56390 A3 SK 56390A3 SK 56390 A SK56390 A SK 56390A SK 56390 A3 SK56390 A3 SK 56390A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
ether
benzyl
process according
Prior art date
Application number
SK563-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK278441B6 (en
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of SK56390A3 publication Critical patent/SK56390A3/sk
Publication of SK278441B6 publication Critical patent/SK278441B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
SK563-90A 1989-02-07 1990-02-06 Ether of 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxy acids, preparation method and intermediate product thereof, pharmaceutical composition containing same and application SK278441B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
SK56390A3 true SK56390A3 (en) 1997-05-07
SK278441B6 SK278441B6 (en) 1997-05-07

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
SK563-90A SK278441B6 (en) 1989-02-07 1990-02-06 Ether of 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxy acids, preparation method and intermediate product thereof, pharmaceutical composition containing same and application

Country Status (36)

Country Link
US (2) US4999367A (fi)
EP (1) EP0382276B1 (fi)
JP (1) JP2870925B2 (fi)
KR (1) KR0145525B1 (fi)
CN (2) CN1046505C (fi)
AR (1) AR247386A1 (fi)
AT (1) ATE127115T1 (fi)
AU (1) AU624895B2 (fi)
BG (1) BG50273A3 (fi)
CA (1) CA2009503C (fi)
CZ (1) CZ280121B6 (fi)
DD (2) DD291995A5 (fi)
DE (2) DE382276T1 (fi)
DK (1) DK0382276T3 (fi)
EG (1) EG19170A (fi)
ES (1) ES2020171T3 (fi)
FI (1) FI102678B (fi)
GE (1) GEP19971030B (fi)
GR (2) GR910300073T1 (fi)
HU (1) HU204793B (fi)
IL (1) IL93132A (fi)
IN (1) IN170957B (fi)
IT (1) IT1230441B (fi)
LT (1) LT3604B (fi)
LV (1) LV10612B (fi)
NZ (1) NZ232258A (fi)
PE (1) PE25091A1 (fi)
PH (1) PH26552A (fi)
PL (2) PL163720B1 (fi)
PT (1) PT93067B (fi)
RO (1) RO106252B1 (fi)
RU (3) RU2066318C1 (fi)
SK (1) SK278441B6 (fi)
UA (1) UA26852C2 (fi)
YU (1) YU47943B (fi)
ZA (1) ZA90644B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EA018976B1 (ru) 2008-03-07 2013-12-30 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии мср-1, cx3cr1 и p40
AU2009221089B2 (en) 2008-03-07 2013-12-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
KR101581829B1 (ko) 2008-03-07 2015-12-31 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸인다졸 유도체들 및 ｍｃｐ-1 및 ｃｘ3ｃｒ1의 발현을 기초로 한 질환들의 치료에서 이의 용도
KR101735577B1 (ko) 2009-08-03 2017-05-15 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸-1ｈ-인다졸과 이의 유도체의 제조 방법
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
WO2013163758A1 (en) 2012-05-01 2013-11-07 Boyd Shelley Romayne Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US9346757B2 (en) 2012-05-18 2016-05-24 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SI2882715T1 (sl) 2012-05-18 2017-03-31 Sanofi Derivati pirazola in njihova uporaba kot antagonisti LPAR5
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) * 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
US5112986A (en) 1992-05-12
EP0382276B1 (en) 1995-08-30
AU624895B2 (en) 1992-06-25
LV10612B (en) 1995-08-20
PE25091A1 (es) 1991-08-17
KR0145525B1 (ko) 1998-08-17
ZA90644B (en) 1991-01-30
NZ232258A (en) 1991-06-25
CN1034016C (zh) 1997-02-12
RU2044729C1 (ru) 1995-09-27
LTIP872A (en) 1995-03-27
RO106252B1 (ro) 1993-03-31
HU900689D0 (en) 1990-04-28
CZ280121B6 (cs) 1995-11-15
HU204793B (en) 1992-02-28
JPH02240065A (ja) 1990-09-25
US4999367A (en) 1991-03-12
ES2020171A4 (es) 1991-08-01
RU2055071C1 (ru) 1996-02-27
PT93067B (pt) 1995-12-29
CN1046505C (zh) 1999-11-17
DD291995A5 (de) 1991-07-18
DE382276T1 (de) 1991-11-28
UA26852C2 (uk) 1999-12-29
IT1230441B (it) 1991-10-23
CN1088201A (zh) 1994-06-22
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
FI900577A0 (fi) 1990-02-06
EP0382276A2 (en) 1990-08-16
IL93132A (en) 1994-05-30
LT3604B (en) 1995-12-27
RU2066318C1 (ru) 1996-09-10
PL163730B1 (pl) 1994-04-29
PH26552A (en) 1992-08-19
YU47943B (sh) 1996-07-24
DE69021902D1 (de) 1995-10-05
IL93132A0 (en) 1990-11-05
CZ56390A3 (en) 1995-06-14
LV10612A (lv) 1995-04-20
FI102678B (fi) 1999-01-29
GR910300073T1 (en) 1991-11-15
AR247386A1 (es) 1994-12-29
CA2009503A1 (en) 1990-08-07
JP2870925B2 (ja) 1999-03-17
ES2020171T3 (es) 1995-12-01
EG19170A (en) 1994-11-30
BG50273A3 (en) 1992-06-15
IN170957B (fi) 1992-06-20
ATE127115T1 (de) 1995-09-15
DE69021902T2 (de) 1996-05-23
DD295363A5 (de) 1991-10-31
YU20690A (sh) 1992-07-20
CA2009503C (en) 2000-04-11
KR900012913A (ko) 1990-09-03
GR3018165T3 (en) 1996-02-29
DK0382276T3 (da) 1996-01-15
AU4906690A (en) 1990-08-16
EP0382276A3 (en) 1990-12-12
PT93067A (pt) 1990-08-31
PL163720B1 (pl) 1994-04-29
SK278441B6 (en) 1997-05-07
CN1044810A (zh) 1990-08-22
HUT53088A (en) 1990-09-28
IT8947620A0 (it) 1989-02-07

Similar Documents

Publication Publication Date Title
SK56390A3 (en) Ether 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxyacids, preparation method of it, intermediate product of this method, pharmaceutical composition containing said ether and use
Sugiura et al. Syntheses and antiinflammatory and hypnotic activity of 5-alkoxy-3-(N-substituted carbamoyl)-1-phenylpyrazoles. 4
US4158005A (en) Intermediates useful in the synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols
NO154294B (no) Doseinhalator.
WO2004110978A2 (en) 1-aminonaphthalenes as modulators of androgen, glucocorticoid, mineralocorticoid and progesterone receptors
SHIBANUMA et al. Synthesis of optically active 2-(N-benzyl-N-methylamino) ethyl methyl 2, 6-dimethyl-4-(m-nitrophenyl)-1, 4-dihydropyridine-3, 5-dicarboxylate (Nicardipine)
EP0172096A1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
EP0267111A1 (fr) Imidazopyridines, leur préparation et leur application en thérapeutique
EP0021857B1 (fr) Dérivés de l'indole, leur préparation et medicaments les contenant
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
US4461894A (en) Naphth[1,2-d]imidazoles
JPH07113015B2 (ja) ３―アミノピロール、その製造方法およびその薬品または薬剤としての使用
JPH0337549B2 (fi)
EP0579129B1 (en) Thiadiazole derivatives for the treatment of depressive states
US4927842A (en) 2,3,4,9-tetrahydro-1H-carbazole acetic acid derivatives, composition and use as anti-inflammatories
US4942176A (en) N-substituted aminoalkanoic acids, a process for their preparation, their use and pharmaceutical products based on these compounds
JPS633866B2 (fi)
JPS6039273B2 (ja) ナフタレン誘導体およびその製造方法
Freed et al. Antidepressants. 1 II. Derivatives of Polynuclear Indoles
US3983127A (en) Pyrrolo[3,4-b]pyridines
Wheatley α, α-Dimethylcholine: Esters and Carbamates1
NO841021L (no) Fremgangsmaate for fremstilling av imidazolinderivater
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
JPS6121636B2 (fi)
US5055590A (en) Preparation of 2,3,4,9-tetrahydro-1H-carbazole acetic acid derivatives

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20100206